Chicago, IL – April 5, 2023 – Today, Zacks Equity Research discusses Inspire Medical Systems INSP, Olink Holding OLK and Health Catalyst HCAT.
Industry: Medical Info Systems
Link: https://www.zacks.com/commentary/2074312/3-medical-info-systems-stocks-countering-industry-wide-headwinds
The past three years of health crisis have led to exponential growth in the Medical Info Systems industry, thanks to the growing demand for contactless services. Even though the severity of the COVID-19 crisis has declined over time, growing demand for a distant treatment option and a paperless environment has led to a tremendous upsurge in digital healthcare options.
Going by Precedence Research data as published by Binariks, the global market for healthcare information systems was worth $287.8 billion in 2022 and is projected to double in size by 2030. Subsequently, 80% of health systems claimed to have plans to increase their investment levels in digital health over the next five years (a HIMSS report).
The growing demand for all kinds of digital healthcare support, including telehealth, cloud computing, artificial intelligence, robotics and analytics, has created a unique opportunity for companies like Inspire Medical Systems, Olink Holding and Health Catalyst. However, with the continued opening up of the global economy despite COVID waves, this trend might get disrupted going forward.
The Zacks Medical Info Systems industry comprises companies, which develop and market healthcare information systems. These companies offer software and hardware solutions to healthcare providers with secure access to real-time clinical, administrative and financial data in a time-efficient manner. Focus on patient satisfaction, security of patient data and administrative cost control has increased the need for big data, 3D printing, blockchain and AI. Industry players like Omnicell and Allscripts are raking in millions from the sale of software and related hardware, professional services and IT outsourcing services, recurring service contracts for software maintenance, and transaction processing services.
Growing Demand for Contactless Services: Amid the pandemic, the need for contactless services has grown enormously. Within the medical information systems space, the telehealth and remote patient monitoring segments are particularly growing at a fast rate. Going by a Forbes article of 2022, telehealth is likely to stay for long, beyond the pandemic and will likely be embedded into the healthcare vernacular and become an everyday part of treating patients. Per a Markets and Markets report, the global remote patient monitoring market is projected to reach $117.1 billion by 2025 from $23.2 billion in 2020, seeing a CAGR of 38.2% between 2020 and 2025.
Subsiding COVID-19 Cases Might Disrupt the Trend: While COVID-19 has introduced an all-new era of virtual healthcare service, it has also brought in associated pitfalls. A Wall Street Journal report says that major insurers have been rolling back the terms of this virtual care coverage, upon which customers are facing out-of-pocket charges on certain virtual visits. Adding to the complication, thanks to the successful vaccination drives globally, the severity of COVID-19 has lessened despite the emergence of more infectious variants.
Accordingly, despite a rise in case count over the past few months, social restrictions have been lifted to a significant extent. This has led to a rise in the number of physician office and hospital visits with a significant reduction in demand for virtual physician appointments. Going by a Healthcare Finance report, insurers are currently wondering how virtual care will look and what it will be like when the pandemic is finally in the rearview mirror.
EMR and Blockchain Gain Ground: Among the long-term trends, EHRs, electronic medical records (EMR), predictive analytics and real-time alerting have been gaining prominence. These have led to the emergence of the Internet of Medical Things, which has enabled the use of a number of wearables, including ECG and EKG monitors, apart from other common medical measurement devices, to determine temperature, glucose level, and blood pressure readings.
The evolution of telemedicine and blockchain is another megatrend worth mentioning here. Leading healthcare companies like Humana, MultiPlan, Quest Diagnostics and UnitedHealth Group’s Optum and UnitedHealthcare formed an alliance to launch the Synaptic Health Alliance pilot project on blockchain.
Rising Instances of Cyber Attacks: As healthcare becomes more wired and interconnected, cybersecurity is the primary concern of hospitals. In fact, security flaws are being increasingly found in electronic medical device operating systems or other devices like ECG machines, imaging scanners, infusion pumps and telemetry systems. Indeed, the pandemic has led to growing cyber dependency, which has made the space vulnerable to cyber-attacks.
The Zacks Medical Info Systems industry falls within the broader Zacks Medical sector. It carries a Zacks Industry Rank #146, which places it in the bottom 42% of more than 250 Zacks industries.
The group's Zacks Industry Rank, which is basically the average of the Zacks Rank of all the member stocks, indicates dull near-term prospects. Our research shows that the top 50% of the Zacks-ranked industries outperforms the bottom 50% by a factor of more than 2 to 1.
We will present a few stocks that have the potential to outperform the market based on a strong earnings outlook. But it’s worth taking a look at the industry’s shareholder returns and current valuation first.
The industry has underperformed the Zacks S&P 500 composite as well as the sector over the past year.
The industry has declined 42.1% compared with the Zacks Medical sector’s decline of 11.6% and the S&P 500’s drop of 15.7% in the said time frame.
On the basis of forward 12-month price-to-sales (P/S), which is commonly used for valuing medical stocks, the industry is currently trading at 23.69X compared with the S&P 500’s 3.58X and the sector’s 2.45X.
Over the last five years, the sector has traded as high as 23.69X, as low as 1.56X, and at the median of 4.01X.
Inspire Medical is a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea. Inspire Medical’s proprietary Inspire therapy is the first and only FDA-approved neurostimulation technology that provides a safe and effective treatment for moderate-to-severe obstructive sleep apnea. Recently, in a major development, the company received FDA approval to offer Inspire therapy to pediatric patients with Down syndrome.
Inspire Medical currently carries a Zacks Rank #2 (Buy). The Zacks Consensus Estimate for 2023 revenues indicates a 39.8% improvement from 2022. In the past six months, the stock has improved 20.6% compared with the S&P 500 Index’s 8.3% growth.
Olink provides various products and services for the academic, government, biopharmaceutical, biotechnology space, service providers, and other institutions that focuse on life science research. The company's products include Olink Explore for cardiovascular and metabolic, oncology, neurology, or inflammation diseases; Olink Target product line; Olink Flex, a low-plex application and use-cases; and the Olink Focus product line that consists of custom-developed solutions for various proteins of interest or a particular protein signature.
Olink currently holds a Zacks Rank #2. The Zacks Consensus Estimate for 2023 revenues indicates 40.3% growth over 2022. In the past six months, the stock has gained 68.3%.
You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Health Catalyst is a leading provider of data and analytics technology and services to healthcare organizations. Health Catalyst’s more than 500 clients leverage the cloud-based data platform or its other software applications — powered by data from over 100 million patient records and encompassing trillions of facts — as well as its analytics software and professional services expertise to make data-informed decisions and realize measurable clinical, financial, and operational improvements.
Health Catalyst carries a Zacks Rank #2 at present. The Zacks Consensus Estimate for 2023 sales indicates year-over-year growth of 6.1%. Over the past six months, the stock has improved 11.2%.
Since 2000, our top stock-picking strategies have blown away the S&P's +6.2 average gain per year. Amazingly, they soared with average gains of +46.4%, +49.5% and +55.2% per year. Today you can access their live picks without cost or obligation.
See Stocks Free >>
Join us on Facebook: https://www.facebook.com/ZacksInvestmentResearch/
Zacks Investment Research is under common control with affiliated entities (including a broker-dealer and an investment adviser), which may engage in transactions involving the foregoing securities for the clients of such affiliates.
Media Contact
Zacks Investment Research
800-767-3771 ext. 9339
support@zacks.com
https://www.zacks.com
Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit https://www.zacks.com/performance for information about the performance numbers displayed in this press release.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Inspire Medical Systems, Inc. (INSP) : Free Stock Analysis Report
Health Catalyst, Inc. (HCAT) : Free Stock Analysis Report
Olink Holding AB (publ) Sponsored ADR (OLK) : Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research
